Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin augmentation of Narrative Exposure Therapy for chronic PTSD
NL-OMON28355Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised trial in post-traumatic stress disorder (PTSD) comparing NET + oxytocin with NET + placebo (2 arms). Primary endpoints: PTSD symptom severity by Clinician-Administered PTSD Scale, PTSD symptom severity by Impact of Event Scale-Revised and 1 more. Started Apr 2013; status: active, not recruiting.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON28355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28355.